Lymphoma Clinical Research
Lymphoma clinical research aims at developing better tolerated and more efficient treatments and at optimising combinations and treatment regimen, for each lymphoma subtype.
LYSARC is the largest European academic oragnization devoted to clinical research operations in the lymphoma field.
LYSARC brings its operational resources and LYSA its scientific experts to several key platforms for the study of lymphoma therapies and biomarkers.
LYSARC puts its operational expertise and its long-standing experience of clinical research in the lymphoma field at the service of LYSA and its academic and industry partners.